Cor Vasa 2025, 67(Suppl.3):24-27 | DOI: 10.33678/cor.2025.021

A multifaceted prosthetic valve infective endocarditis

Mario Di Marinoa, b†, Eugenio Genovesib†, Alessandro Corazzinib, Roberta Magnanob, Alberto D'Allevab, Sabina Gallinaa, Massimo Di Marcob
a Department of Neuroscience, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
b Cardiology and ICCU Department, Santo Spirito Hospital, 65124 Pescara, Italy These authors contributed equally to this work.

Infective endocarditis is a significant public health challenge, with high mortality and morbidity. A 79-year-old man, post-aortic bioprosthetic implantation, presented with chest pain. An electrocardiogram indicated anterior ST-elevation myocardial infarction. Urgent coronary angiography showed critical left anterior descending artery stenosis, treated with angioplasty and a drug-eluting stent. Transthoracic and transesophageal echocardiograms revealed nosocomial endocarditis on the aortic bioprosthetic and a significant peri-prosthetic abscess. Blood cultures identified multidrug-resistant Staphylococcus haemolyticus. Despite surgical recommendations, the patient opted for intra-hospital antibiotic therapy and home care after repeated transesophageal echocardiograms. Remarkably, this case underscores the rare and significant success of conservative therapy in resolving a paravalvular abscess, a condition typically necessitating surgical intervention. This extraordinary outcome highlights the potential for non-surgical management in selected cases. The patient remains in good health upon follow-up, emphasizing the importance of multidisciplinary care and vigilant monitoring.

Keywords: Acute myocardial infarction, Infectious endocarditis, Inflammatory state, Outpatient parental antimicrobial therapy, Transesophageal echocardiography

Received: January 8, 2025; Revised: February 2, 2025; Accepted: February 2, 2025; Prepublished online: June 2, 2012; Published: September 1, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Di Marino M, b†, Genovesi E, Corazzini A, Magnano R, D'Alleva A, et al.. A multifaceted prosthetic valve infective endocarditis. Cor Vasa. 2025;67(Suppl.3):24-27. doi: 10.33678/cor.2025.021.
Download citation

References

  1. Global Burden of Disease Metrics. Institute for Health Metrics Evaluation. University of Washington, Seattle. Online. Dostupné z: https://vizhub.healthdata.org/gbd-compare [citováno 2025-08-13].
  2. Delgado V, Ajmone Marsan N, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023;44:3948-4042. Erratum in: Eur Heart J 2023;44:4780. Go to original source... Go to PubMed...
  3. Momtazmanesh S, Saeedi Moghaddam S, Malakan Rad E, et al. Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990-2019. Eur J Prev Cardiol 2022;29:1287-1297. Go to original source... Go to PubMed...
  4. Manzano MC, Vilacosta I, San Román JA, et al. Síndrome coronario agudo en la endocarditis infecciosa [Acute coronary syndrome in infective endocarditis]. Rev Esp Cardiol 2007;60:24-31. Spanish. Go to original source...
  5. Wang H, Liu Z, Shao J, et al. Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications. J Immunol Res 2020;2020:4904217. Go to original source... Go to PubMed...
  6. López-Mejías R, Castañeda S, González-Juanatey C, et al. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers. Autoimmun Rev 2016;15:1013-1030. Go to original source... Go to PubMed...
  7. Lee SN, Moon D, Moon KW, Yoo KD. The Glasgow prognostic score as a significant predictor of clinical outcomes in patients with acute coronary syndrome. J Cardiol 2019;74:130-135. Go to original source... Go to PubMed...
  8. Dixon WG, Watson KD, Lunt M, et al. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007;56:2905-2912. Go to original source... Go to PubMed...
  9. Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med 2019;381:2497-2505. Go to original source... Go to PubMed...
  10. Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med 2020;383:1838-1847. Go to original source... Go to PubMed...
  11. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720-3826. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.